Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Dr. Eric Small
Based on 119 articles published since 2007
||||
Expertise Level
The expertise of Dr. Eric Small ranks in the
  • Top 0.019%
  • ... of 131,386 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 119 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Small, Eric Jay   ·   Small, Eric   ·   Small, E J   ·   Small, E   ·   Small, Eric J
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • a Department of Medicine , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 28532278
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Mayo Scottsdale Cancer Center, Scottsdale, AZ. · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Department of Medicine, Vanderbilt University, Nashville, TN. · Pubmed 28161323
  • University of California, San Francisco, CA, USA. Electronic address: · Pubmed 28697343
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Pathology, Duke University, Durham, North Carolina. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California. · Pubmed 28592703
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. Electronic address: · Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Pathology, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, Duke University School of Medicine, Durham, North Carolina. · Department of Medicine, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 28549709
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Urology, University of California San Francisco, San Francisco, California; and. · Department of Radiation Oncology, University of California San Francisco, San Francisco, California. · Pubmed 28522741
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California. · Department of Radiology, Mayo Clinic, Rochester, Minnesota. · Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California; and. · Department of Urology, University of California, San Francisco, San Francisco, California. · Pubmed 27660139
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • a Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 26698365
  • Department of Radiology and Biomedical Imaging, University of California, 185 Berry Street, Lobby 6, Suite 350, San Francisco, CA, 94107, USA. · Department of Medicine, University of California, 505 Parnassus Avenue, San Francisco, CA, 94143, USA. · Department of Radiology and Biomedical Imaging, University of California, 185 Berry Street, Lobby 6, Suite 350, San Francisco, CA, 94107, USA. · Pubmed 27184068
  • Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan. UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Duke Cancer Institute, Durham, North Carolina. Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland. · Department of Medicine, University of Chicago, Chicago, Illinois. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Thomas Jefferson University, Philadelphia, Pennsylvania. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. · Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. · Duke Cancer Institute, Durham, North Carolina. · Life Sciences Institute, University of Michigan, Ann Arbor, Michigan. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, the Netherlands. · Department of Medicine, UCSF, San Francisco, California. · Genomic Health, Redwood City, California. · Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina. · Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. · The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. · Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan. · Memorial Sloan Kettering Cancer Center, New York. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida. · Pubmed 27143689
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Urology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Hematology and Medical Oncology Cleveland, Clinic Taussig Cancer Institute, Cleveland, Ohio. · Department of Urology, University of California, San Diego, La Jolla, California. · Department of Anatomic Pathology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27688020
  • Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Computational Biology Core, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Genome Analysis Core, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA. Electronic address: · Pubmed 27343980
2015
  • a UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 26488270
  • Division of Hematology/Oncology, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25968455
  • UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Eastern Virginia Medical School/Urology of Virginia PLLC, Norfolk, Virginia. · Department of Urology at Indiana University School of Medicine, Indianapolis, Indiana. · The Urology Center of Colorado, Denver, Colorado. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Dendreon Pharmaceuticals, Inc., Seattle, Washington. · Sharp Clinical Oncology Research, San Diego, California. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Pubmed 25925891
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
2014
  • University of California, San Francisco, San Francisco, CA · Pubmed 25311216
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Molecular Pharmacology, City of Hope, Duarte, CA, USA. · Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. · Atara Biotherapeutics, Westlake Village, CA, USA. · Janssen Research and Development, Los Angeles, CA, USA. · Pubmed 25047002
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Massachusetts General Hospital Cancer Center, Boston, MA · Duke University Medical Center, Durham, NC. · University of California, San Francisco, San Francisco, CA. · Pubmed 25225438
2011
  • Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Pubmed 22361784
  • University of California, San Francisco, Comprehensive Cancer Center, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. · Pubmed 21859996
2007
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 17822457
  • University of California, San Francisco, Comprehensive Cancer Center, San Francisco, California 94115, USA. · Pubmed 17606721
  • UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 17363537
2018
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.); Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.); Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.); Georges Pompidou Hospital, Paris (S.O.); University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.); Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.); Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.); Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.); St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.); Yokohama City University Medical Center, Yokohama, Japan (H.U.); Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.); and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • From the aDepartment of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, and Department of Medicine, and bDepartment of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina. · Pubmed 24812138
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (LF, PC, VW, SC, JL, JS, EJS); Virginia Mason Medical Center, Seattle, WA (JC); Oregon Health & Science University, Portland, OR (CLA); University of Utah School of Medicine, Salt Lake City, UT (RAS); Dendreon Corporation, Seattle, WA (NAS, RBS, MWF). · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (LF, PC, VW, SC, JL, JS, EJS); Virginia Mason Medical Center, Seattle, WA (JC); Oregon Health & Science University, Portland, OR (CLA); University of Utah School of Medicine, Salt Lake City, UT (RAS); Dendreon Corporation, Seattle, WA (NAS, RBS, MWF). · Pubmed 25255802
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Medicine, University of California, San Francisco, California 94143, USA. · Pubmed 23634292
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 23913744
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23816964
  • Surbeck Laboratory of Advanced Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94158, USA. · Pubmed 23946197
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 23228172
2012
  • Division of Hematology/Oncology, Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA. · Pubmed 22956585
  • Genitourinary Medical Oncology Program, Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, Department of Bioengineering and Therapeutic Sciences, Box 1711, 1600 Divisadaro Street, University of California, San Francisco, San Francisco, CA 94115-1711, USA. · Pubmed 21971890
  • Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 20884247
2011
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Pubmed 24048789
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 21632851
2010
  • University of California, Urologic Oncology, San Francisco, CA 94143, · Pubmed 20307219
  • UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA 94115, USA. · Pubmed 20014889
  • Urologic Oncology Program, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 20159824
2009
  • Department of Medicine, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 19342474
  • Urologic Oncology Program, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 19815485
  • Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California 94143, USA. · Pubmed 19147575
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
2008
  • Department of Medicine, University of California, San Francisco, California, USA. · Pubmed 18536785
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 18391629
  • Department of Microbiology and Immunology, Division of Hematology/Oncology, University of California, San Francisco, CA 94143, USA. · Pubmed 18523152
  • Department of Medicine and the [corrected] UCSF Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA. · Pubmed 18234062
2007
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 18685361
  • Department of Medicine, and UCSF Comprehensive Cancer Center, University of California-San Francisco, 94143, USA. · Pubmed 17913662
  • University of California, Department of Medicine, Urologic Oncology 231, San Francisco, CA 94115, USA. · Pubmed 17696825
  • University of California, San Francisco, San Francisco, CA 94143-0511, USA. · Pubmed 17430695
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 17414641
  • Urologic Oncology Program, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 17936834
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 17645829
  • Department of Medicine, University of California at San Francisco, Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 17577218
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, 1600 Divisadero-3rd Floor, San Francisco, CA, USA. · Pubmed 17458505
  • Urologic Oncology Program, University of California,/San Francisco, California 94143, USA. · Pubmed 17404083
  • Department of Medicine, University of California-San Francisco, San Francisco, CA, USA. · Pubmed 17407512
  • Department of Medicine, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. <> · Pubmed 17349528
Probable:    Miscellaneous cities in USA      
2015
  • Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA; Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. Electronic address: · Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA; Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. · Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. · Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA. · Department of Psychiatry,University of CaliforniaSan Francisco, USA. · Radiation Oncology, University of California, San Francisco, USA. · Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA; Department of Medicine, Division of Hematology and Oncology,University of CaliforniaSan Francisco, USA. · Pubmed 26435199
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 119 total) written by Dr. Eric Small about Prostatic Neoplasms:

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. 2018
  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment. 2017
  • A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study. 2017
  • Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. 2017
  • Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies. 2017
  • Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer. 2017
  • CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield. 2017
  • Impact of 2017
  • Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. 2017
Show List of Full Article Records
Google Searches

Learn more about Dr. Eric Small using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Miscellaneous cities in USA
Affiliation Timeline What is this?
University of California San Francisco
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • a Department of Medicine , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 28532278
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Mayo Scottsdale Cancer Center, Scottsdale, AZ. · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Department of Medicine, Vanderbilt University, Nashville, TN. · Pubmed 28161323
  • University of California, San Francisco, CA, USA. Electronic address: · Pubmed 28697343
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Pathology, Duke University, Durham, North Carolina. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California. · Pubmed 28592703
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. Electronic address: · Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 513 Parnassus Avenue, S-261, San Francisco, CA 94143-0628. · Department of Pathology, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, Duke University School of Medicine, Durham, North Carolina. · Department of Medicine, Oregon Health & Science University, Portland, Oregon; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Pubmed 28549709
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Urology, University of California San Francisco, San Francisco, California; and. · Department of Radiation Oncology, University of California San Francisco, San Francisco, California. · Pubmed 28522741
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California. · Department of Radiology, Mayo Clinic, Rochester, Minnesota. · Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California; and. · Department of Urology, University of California, San Francisco, San Francisco, California. · Pubmed 27660139
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • a Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 26698365
  • Department of Radiology and Biomedical Imaging, University of California, 185 Berry Street, Lobby 6, Suite 350, San Francisco, CA, 94107, USA. · Department of Medicine, University of California, 505 Parnassus Avenue, San Francisco, CA, 94143, USA. · Department of Radiology and Biomedical Imaging, University of California, 185 Berry Street, Lobby 6, Suite 350, San Francisco, CA, 94107, USA. · Pubmed 27184068
  • Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan. UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Duke Cancer Institute, Durham, North Carolina. Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland. · Department of Medicine, University of Chicago, Chicago, Illinois. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina. · Thomas Jefferson University, Philadelphia, Pennsylvania. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. · Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. · Duke Cancer Institute, Durham, North Carolina. · Life Sciences Institute, University of Michigan, Ann Arbor, Michigan. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, the Netherlands. · Department of Medicine, UCSF, San Francisco, California. · Genomic Health, Redwood City, California. · Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina. · Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. · The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. · Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan. · Memorial Sloan Kettering Cancer Center, New York. · UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida. · Pubmed 27143689
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Urology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Hematology and Medical Oncology Cleveland, Clinic Taussig Cancer Institute, Cleveland, Ohio. · Department of Urology, University of California, San Diego, La Jolla, California. · Department of Anatomic Pathology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27688020
  • Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Computational Biology Core, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Genome Analysis Core, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA. · Department of Urology, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology & Oncology, University of California, San Francisco (UCSF), San Francisco, CA, USA. Electronic address: · Pubmed 27343980
2015
  • a UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA. · Pubmed 26488270
  • Division of Hematology/Oncology, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25968455
  • UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Eastern Virginia Medical School/Urology of Virginia PLLC, Norfolk, Virginia. · Department of Urology at Indiana University School of Medicine, Indianapolis, Indiana. · The Urology Center of Colorado, Denver, Colorado. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Dendreon Pharmaceuticals, Inc., Seattle, Washington. · Sharp Clinical Oncology Research, San Diego, California. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Pubmed 25925891
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
2014
  • University of California, San Francisco, San Francisco, CA · Pubmed 25311216
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Molecular Pharmacology, City of Hope, Duarte, CA, USA. · Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. · Atara Biotherapeutics, Westlake Village, CA, USA. · Janssen Research and Development, Los Angeles, CA, USA. · Pubmed 25047002
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Massachusetts General Hospital Cancer Center, Boston, MA · Duke University Medical Center, Durham, NC. · University of California, San Francisco, San Francisco, CA. · Pubmed 25225438
2011
  • Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Pubmed 22361784
  • University of California, San Francisco, Comprehensive Cancer Center, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. · Pubmed 21859996
2007
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 17822457
  • University of California, San Francisco, Comprehensive Cancer Center, San Francisco, California 94115, USA. · Pubmed 17606721
  • UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 17363537
2018
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.); Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.); Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.); Georges Pompidou Hospital, Paris (S.O.); University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.); Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.); Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.); Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.); St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.); Yokohama City University Medical Center, Yokohama, Japan (H.U.); Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.); and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • From the aDepartment of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, and Department of Medicine, and bDepartment of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina. · Pubmed 24812138
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (LF, PC, VW, SC, JL, JS, EJS); Virginia Mason Medical Center, Seattle, WA (JC); Oregon Health & Science University, Portland, OR (CLA); University of Utah School of Medicine, Salt Lake City, UT (RAS); Dendreon Corporation, Seattle, WA (NAS, RBS, MWF). · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (LF, PC, VW, SC, JL, JS, EJS); Virginia Mason Medical Center, Seattle, WA (JC); Oregon Health & Science University, Portland, OR (CLA); University of Utah School of Medicine, Salt Lake City, UT (RAS); Dendreon Corporation, Seattle, WA (NAS, RBS, MWF). · Pubmed 25255802
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Medicine, University of California, San Francisco, California 94143, USA. · Pubmed 23634292
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 23913744
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23816964
  • Surbeck Laboratory of Advanced Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94158, USA. · Pubmed 23946197
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 23228172
2012
  • Division of Hematology/Oncology, Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA. · Pubmed 22956585
  • Genitourinary Medical Oncology Program, Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, Department of Bioengineering and Therapeutic Sciences, Box 1711, 1600 Divisadaro Street, University of California, San Francisco, San Francisco, CA 94115-1711, USA. · Pubmed 21971890
  • Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 20884247
2011
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Pubmed 24048789
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 21632851
2010
  • University of California, Urologic Oncology, San Francisco, CA 94143, · Pubmed 20307219
  • UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA 94115, USA. · Pubmed 20014889
  • Urologic Oncology Program, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 20159824
2009
  • Department of Medicine, University of California San Francisco, San Francisco, CA 94115, USA. · Pubmed 19342474
  • Urologic Oncology Program, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 19815485
  • Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California 94143, USA. · Pubmed 19147575
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
2008
  • Department of Medicine, University of California, San Francisco, California, USA. · Pubmed 18536785
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 18391629
  • Department of Microbiology and Immunology, Division of Hematology/Oncology, University of California, San Francisco, CA 94143, USA. · Pubmed 18523152
  • Department of Medicine and the [corrected] UCSF Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA. · Pubmed 18234062
2007
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 18685361
  • Department of Medicine, and UCSF Comprehensive Cancer Center, University of California-San Francisco, 94143, USA. · Pubmed 17913662
  • University of California, Department of Medicine, Urologic Oncology 231, San Francisco, CA 94115, USA. · Pubmed 17696825
  • University of California, San Francisco, San Francisco, CA 94143-0511, USA. · Pubmed 17430695
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. · Pubmed 17414641
  • Urologic Oncology Program, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 17936834
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 17645829
  • Department of Medicine, University of California at San Francisco, Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 17577218
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, 1600 Divisadero-3rd Floor, San Francisco, CA, USA. · Pubmed 17458505
  • Urologic Oncology Program, University of California,/San Francisco, California 94143, USA. · Pubmed 17404083
  • Department of Medicine, University of California-San Francisco, San Francisco, CA, USA. · Pubmed 17407512
  • Department of Medicine, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. <> · Pubmed 17349528
Miscellaneous cities in USA
2015
  • Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA; Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. Electronic address: · Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA; Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. · Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA. · Department of Medicine, Division of General Internal Medicine,University of CaliforniaSan Francisco, USA. · Department of Psychiatry,University of CaliforniaSan Francisco, USA. · Radiation Oncology, University of California, San Francisco, USA. · Helen Diller Family Comprehensive Cancer Center,University of CaliforniaSan Francisco, USA; Department of Medicine, Division of Hematology and Oncology,University of CaliforniaSan Francisco, USA. · Pubmed 26435199
80 Other Locations Show
Yearly article counts 112913141077791317